Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19

L Acharya, A Garg, M Rai, R Kshetri… - Journal of …, 2024 - journals.sagepub.com
… remodeling and increased cell activation. Trivalent CAR T cells … the antigen receptor, provide
the inhibitory signal, and allow the possibility to regulate the strength of this inhibitory signal

[HTML][HTML] Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia

C Schorr, F Perna - Frontiers in Immunology, 2022 - frontiersin.org
signaling, inflammation, and serves as a negative regulator … B-cell activation thresholds
via B-cell receptor-dependent and … that B7-H3 serves as an inhibitor to T-cell cytotoxicity and …

Mechanisms of B cell receptor activation and responses to B cell receptor inhibitors in B cell malignancies

DG Efremov, S Turkalj, L Laurenti - Cancers, 2020 - mdpi.com
… BCR activation in GCB DLBCL, we recently investigated the expression of several negative
regulators … Beside infection, chronic antigen stimulation in the context of certain autoimmune

Thyroid dysfunction and diabetes mellitus: two closely associated disorders

B Biondi, GJ Kahaly, RP Robertson - Endocrine reviews, 2019 - academic.oup.com
… T1D is due to autoimmune β cell destruction, usually … T cell activation: the HLA-DR molecules
present autoantigens to T cells, PTPN22 negatively influences the T cell receptor signaling

MicroRNA control of B cell tolerance, autoimmunity and cancer

C Xiao, D Nemazee, A Gonzalez-Martin - Seminars in cancer biology, 2020 - Elsevier
… B cell activating factor (BAFF) acts as a survival factor for … autoimmunity by functioning as
a negative regulator of T cell … CD4 T cell expansion and Th1 function, and inhibited TGFβ-…

Regulation of B-cell receptor signaling and its therapeutic relevance in aggressive B-cell lymphomas

N Profitós-Pelejà, JC Santos, A Marín-Niebla, G Roué… - Cancers, 2022 - mdpi.com
… in DLBCL and MCL and will cover both approved inhibitors … supporting that several
autoimmune diseases are risk factors … ; loss of function mutations in A20 (a NF-κB negative

IL-10 signaling in the tumor microenvironment of ovarian cancer

…, BK Kolli, R Dachepalli, PS Umar, SK Rai… - … : The Role of Interleukins …, 2021 - Springer
… efficacy of DC and chimeric antigen receptor T-cell vaccines will be … pathways that ward off
autoimmunity during immune responses … We posit that blocking either regulator T cells or their …

[HTML][HTML] Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases

YZ Hu, Q Li, PF Wang, XP Li, ZL Hu - Frontiers in Oncology, 2023 - frontiersin.org
… as prognostic tool in B cell lymphoma, autoimmune diseases and immune-mediated disorders,
… ) levels, thereby inhibiting the expression of the B-cell activation factor receptor (BAFF-R), …

RAGE and its ligands: from pathogenesis to therapeutics

N Jangde, R Ray, V Rai - Critical reviews in biochemistry and …, 2020 - Taylor & Francis
blocking of ERK1/2 activation. These signaling pathways are involved in the regulation of …
RAGE association with AGEs, HMGB1 and S100A9 protein in endothelial cell activate PI3K, …

[HTML][HTML] Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus

F Olayinka-Adefemi, S Hou, AJ Marshall - Frontiers in Immunology, 2023 - frontiersin.org
lymphocytes, the activation of class 1 PI3Ks is controlled by antigen receptor, co-stimulatory
receptors… effect of inhibiting both the PI3Kδ and PI3Kγ isoforms on autoimmune phenotypes …